Posted by admin on Jul 15th, 2022

DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued on Wednesday.

Other research analysts also recently issued research reports about the company. Morgan Stanley reduced their price objective on DENTSPLY SIRONA from $62.00 to $52.00 and set an “overweight” rating for the company in a research note on Wednesday, April 20th. Piper Sandler reduced their price objective on DENTSPLY SIRONA from $41.00 to $38.00 in a research note on Monday. HC Wainwright reduced their price objective on DENTSPLY SIRONA from $58.00 to $48.00 and set a “hold” rating for the company in a research note on Friday, April 22nd. William Blair cut DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Tuesday, April 19th. Finally, TheStreet cut DENTSPLY SIRONA from a “b-” rating to a “c+” rating in a research report on Friday, March 18th. Seven investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $49.67.

Shares of DENTSPLY SIRONA stock opened at $34.20 on Wednesday. The stock has a fifty day simple moving average of $37.47 and a 200 day simple moving average of $46.29. DENTSPLY SIRONA has a 12-month low of $33.78 and a 12-month high of $66.98. The company has a market capitalization of $7.37 billion, a P/E ratio of 20.51 and a beta of 0.94. The company has a current ratio of 1.45, a quick ratio of 1.03 and a debt-to-equity ratio of 0.38.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last announced its quarterly earnings results on Tuesday, May 10th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.02. DENTSPLY SIRONA had a return on equity of 11.63% and a net margin of 8.81%. The business had revenue of $9.67 billion during the quarter, compared to the consensus estimate of $982.05 million. During the same quarter in the prior year, the company posted $0.72 earnings per share. DENTSPLY SIRONA’s revenue was up 841.1% compared to the same quarter last year. On average, analysts predict that DENTSPLY SIRONA will post 2.42 EPS for the current year.

In related news, Director Eric Brandt sold 6,900 shares of the firm’s stock in a transaction that occurred on Tuesday, May 3rd. The stock was sold at an average price of $39.71, for a total transaction of $273,999.00. Following the transaction, the director now directly owns 35,155 shares in the company, valued at approximately $1,396,005.05. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. 0.76% of the stock is owned by company insiders.

Institutional investors and hedge funds have recently bought and sold shares of the stock. SOA Wealth Advisors LLC. grew its position in DENTSPLY SIRONA by 26,666.7% during the 1st quarter. SOA Wealth Advisors LLC. now owns 803 shares of the medical instruments supplier’s stock worth $39,000 after acquiring an additional 800 shares during the last quarter. Parkside Financial Bank & Trust grew its position in shares of DENTSPLY SIRONA by 33.8% in the 2nd quarter. Parkside Financial Bank & Trust now owns 1,224 shares of the medical instruments supplier’s stock worth $43,000 after buying an additional 309 shares during the last quarter. National Bank of Canada FI bought a new stake in shares of DENTSPLY SIRONA in the 4th quarter worth approximately $55,000. Dixon Hughes Goodman Wealth Advisors LLC bought a new stake in shares of DENTSPLY SIRONA in the 1st quarter worth approximately $79,000. Finally, Covestor Ltd bought a new stake in shares of DENTSPLY SIRONA in the 4th quarter worth approximately $90,000. Institutional investors and hedge funds own 94.79% of the company’s stock.

DENTSPLY SIRONA Company Profile (Get Rating)

DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

Pacific Health Care Organization (OTCMKTS:PFHO) versus Convey Health Solutions (NYSE:CNVY) Critical Review

Lundin Mining (TSE:LUN) Downgraded by The Goldman Sachs Group to “Hold”